Resultados da pesquisa - Nicole J. Ullrich

Refinar resultados
  1. 1
    Astrocyte Na+ channels are required for maintenance of Na+/K(+)-ATPase activity

    Astrocyte Na+ channels are required for maintenance of Na+/K(+)-ATPase activity Por Harald Sontheimer, Elizabeth Fernandez-Marques, Nicole J. Ullrich, CA Pappas, S. G. Waxman

    Publicado em 1994
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  2. 2
    Developing Interventions for Cancer-Related Cognitive Dysfunction in Childhood Cancer Survivors

    Developing Interventions for Cancer-Related Cognitive Dysfunction in Childhood Cancer Survivors Por Sharon M. Castellino, Nicole J. Ullrich, Megan J. Whelen, Beverly J. Lange

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  3. 3
    Incidence, risk factors, and longitudinal outcome of seizures in long-term survivors of pediatric brain tumors

    Incidence, risk factors, and longitudinal outcome of seizures in long-term survivors of pediatric brain tumors Por Nicole J. Ullrich, Scott L. Pomeroy, Kush Kapur, Peter Manley, Liliana Goumnerova, Tobias Loddenkemper

    Publicado em 2015
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  4. 4
    Imaging Characteristics of Cerebrovascular Arteriopathy and Stroke in Hutchinson-Gilford Progeria Syndrome

    Imaging Characteristics of Cerebrovascular Arteriopathy and Stroke in Hutchinson-Gilford Progeria Syndrome Por V. Michelle Silvera, L.B. Gordon, Darren B. Orbach, S. E. Campbell, Jason T. Machan, Nicole J. Ullrich

    Publicado em 2012
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  5. 5
    Discovery of asymptomatic moyamoya arteriopathy in pediatric syndromic populations: radiographic and clinical progression

    Discovery of asymptomatic moyamoya arteriopathy in pediatric syndromic populations: radiographic and clinical progression Por Ning Lin, Lissa Baird, McKenzie Koss, Kimberly Kopecky, Evelyne Gone, Nicole J. Ullrich, R. Michael Scott, Edward R. Smith

    Publicado em 2011
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  6. 6
    Self-reported access to specialty clinics and receipt of health surveillance among U.S. patients with neurofibromatosis 1: a national survey

    Self-reported access to specialty clinics and receipt of health surveillance among U.S. patients with neurofibromatosis 1: a national survey Por Vanessa L. Merker, Yidan Ma, Lori B. Chibnik, Heather B. Radtke, Kate Kelts, Kaleb Yohay, Nicole J. Ullrich, Scott R. Plotkin, Justin T. Jordan

    Publicado em 2025
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  7. 7
    Neurologic features of Hutchinson-Gilford progeria syndrome after lonafarnib treatment

    Neurologic features of Hutchinson-Gilford progeria syndrome after lonafarnib treatment Por Nicole J. Ullrich, Mark W. Kieran, David T. Miller, Leslie B. Gordon, Yoon-Jae Cho, V. Michelle Silvera, Anita Giobbie‐Hurder, Donna Neuberg, Monica E. Kleinman

    Publicado em 2013
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  8. 8
    The Use of MEK Inhibitors in Neurofibromatosis Type 1–Associated Tumors and Management of Toxicities

    The Use of MEK Inhibitors in Neurofibromatosis Type 1–Associated Tumors and Management of Toxicities Por Laura J. Klesse, Justin T. Jordan, Heather B. Radtke, Tena Rosser, Elizabeth K. Schorry, Nicole J. Ullrich, David Viskochil, Pamela Knight, Scott R. Plotkin, Kaleb Yohay

    Publicado em 2020
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  9. 9
    Peripheral neuropathy in children and adolescents treated for cancer

    Peripheral neuropathy in children and adolescents treated for cancer Por Kari Bjornard, Laura Gilchrist, Hiroto Inaba, B Diouf, Marilyn Hockenberry, Nina S. Kadan‐Lottick, Daniel C. Bowers, M. Eileen Dolan, Nicole J. Ullrich, William E. Evans, Kirsten K. Ness

    Publicado em 2018
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  10. 10
    Functional outcome measures for NF1-associated optic pathway glioma clinical trials

    Functional outcome measures for NF1-associated optic pathway glioma clinical trials Por Michael J. Fisher, Robert A. Avery, Jeffrey C. Allen, Simone Ardern‐Holmes, Larissa T. Bilaniuk, Rosalie E. Ferner, David H. Gutmann, Robert Listernick, Staci Martin, Nicole J. Ullrich, Grant T. Liu

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  11. 11
    Phase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromas

    Phase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromas Por Regina I. Jakacki, Eva Dombi, Seth M. Steinberg, Stewart Goldman, Mark W. Kieran, Nicole J. Ullrich, Ian F. Pollack, Anne Goodwin, Peter Manley, Jason Fangusaro, Rudy Allen, Brigitte C. Widemann

    Publicado em 2016
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  12. 12
    Long‐term clinical outcomes following treatment of childhood craniopharyngioma

    Long‐term clinical outcomes following treatment of childhood craniopharyngioma Por Karen M. Winkfield, Henry Tsai, Xiaopan Yao, Elysia Larson, Donna Neuberg, Scott L. Pomeroy, Nicole J. Ullrich, Laurie E. Cohen, Mark W. Kieran, R. Michael Scott, Liliana Goumnerova, Karen J. Marcus

    Publicado em 2010
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  13. 13
    Long‐term outcome of 4,040 children diagnosed with pediatric low‐grade gliomas: An analysis of the Surveillance Epidemiology and End Results (SEER) database

    Long‐term outcome of 4,040 children diagnosed with pediatric low‐grade gliomas: An analysis of the Surveillance Epidemiology and End Results (SEER) database Por Pratiti Bandopadhayay, Guillaume Bergthold, Wendy B. London, Liliana Goumnerova, Andrés Morales La Madrid, Karen J. Marcus, Dongjing Guo, Nicole J. Ullrich, Nathan Robison, Susan Chi, Rameen Beroukhim, Mark W. Kieran, Peter Manley

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  14. 14
    Longitudinal assessment of late-onset neurologic conditions in survivors of childhood central nervous system tumors: a Childhood Cancer Survivor Study report

    Longitudinal assessment of late-onset neurologic conditions in survivors of childhood central nervous system tumors: a Childhood Cancer Survivor Study report Por Elizabeth Wells, Nicole J. Ullrich, Kristy Seidel, Wendy M. Leisenring, Charles A. Sklar, Gregory T. Armstrong, Lisa Diller, Allison A. King, Kevin R. Krull, Joseph P. Neglia, Marilyn Stovall, Kimberly Whelan, Kevin C. Oeffinger, Leslie L. Robison, Roger J. Packer

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  15. 15
    Sirolimus for progressive neurofibromatosis type 1-associated plexiform neurofibromas: a Neurofibromatosis Clinical Trials Consortium phase II study

    Sirolimus for progressive neurofibromatosis type 1-associated plexiform neurofibromas: a Neurofibromatosis Clinical Trials Consortium phase II study Por Brian Weiss, Brigitte C. Widemann, Pamela L. Wolters, Eva Dombi, Alexander A. Vinks, Alan Cantor, John P. Perentesis, Elizabeth K. Schorry, Nicole J. Ullrich, David H. Gutmann, J. Tonsgard, David Viskochil, Bruce R. Korf, Roger J. Packer, Michael J. Fisher

    Publicado em 2014
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  16. 16
    Rethinking childhood ependymoma: a retrospective, multi-center analysis reveals poor long-term overall survival

    Rethinking childhood ependymoma: a retrospective, multi-center analysis reveals poor long-term overall survival Por Amanda Marinoff, Clement Ma, Dongjing Guo, Matija Snuderl, Karen Wright, Peter Manley, Hasan Al‐Sayegh, Claire Sinai, Nicole J. Ullrich, Karen J. Marcus, Daphne A. Haas‐Kogan, Liliana Goumnerova, Wendy B. London, Mark W. Kieran, Susan Chi, Jason Fangusaro, Pratiti Bandopadhayay

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  17. 17
    Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis

    Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis Por MJ Fisher, Michael J. Loguidice, David H. Gutmann, Robert Listernick, Rosalie E. Ferner, Nicole J. Ullrich, R. J. Packer, Uri Tabori, Robert Hoffman, Simone Ardern‐Holmes, Trent R. Hummel, Darren Hargrave, Éric Bouffet, Joel Charrow, Larissa T. Bilaniuk, Laura J. Balcer, G. T. Liu

    Publicado em 2012
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  18. 18
    Long-term neurologic health and psychosocial function of adult survivors of childhood medulloblastoma/PNET: a report from the Childhood Cancer Survivor Study

    Long-term neurologic health and psychosocial function of adult survivors of childhood medulloblastoma/PNET: a report from the Childhood Cancer Survivor Study Por Allison A. King, Kristy Seidel, Chongzhi Di, Wendy M. Leisenring, Stephanie M. Perkins, Kevin R. Krull, Charles A. Sklar, Daniel M. Green, Gregory T. Armstrong, Lonnie K. Zeltzer, Elizabeth Wells, Marilyn Stovall, Nicole J. Ullrich, Kevin C. Oeffinger, Leslie L. Robison, Roger J. Packer

    Publicado em 2016
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  19. 19
    Multicenter, prospective, phase 2 study of maintenance bevacizumab for children and adults with <i>NF2</i>-related schwannomatosis and progressive vestibular schwannoma

    Multicenter, prospective, phase 2 study of maintenance bevacizumab for children and adults with <i>NF2</i>-related schwannomatosis and progressive vestibular schwannoma Por Scott R. Plotkin, Jeffrey C. Allen, Girish Dhall, Jian L. Campian, D. Wade Clapp, Michael J. Fisher, Rakesh K. Jain, James H. Tonsgard, Nicole J. Ullrich, Coretta Thomas, Lloyd J. Edwards, Bruce R. Korf, Roger J. Packer, Matthias A. Karajannis, Jaishri O. Blakeley

    Publicado em 2023
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  20. 20
    Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma

    Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma Por Scott R. Plotkin, Dan G. Duda, Alona Muzikansky, Jeffrey C. Allen, Jaishri O. Blakeley, Tena Rosser, Jian L. Campian, D. Wade Clapp, Michael J. Fisher, James H. Tonsgard, Nicole J. Ullrich, Coretta Thomas, Gary Cutter, Bruce R. Korf, Roger J. Packer, Matthias A. Karajannis

    Publicado em 2019
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:

Ferramentas de pesquisa: